Rezultati pretrage - Beata Maćkowiak-Matejczyk
- Prikaz rezultata 1 – 6 od 6
-
1
Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses od Katarzyna M. Terlikowska, Bożena Dobrzycka, Anna Maria Witkowska, Beata Maćkowiak-Matejczyk, Tomasz Kamil Sledziewski, Maciej Kinalski, S Terlikowski
Izdano 2016Artigo -
2
O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study od Rebecca Kristeleit, Alla Lisyanskaya, А. А. Феденко, Mikhail Dvorkin, Andréia Cristina de Melo, Y. Shparyk, Irina Rakhmatullina, Igor Bondarenko, Nicoletta Colombo, Valentyn Svintsitskiy, Luciano Biela, M. Nechaeva, Francesco Raspagliesi, Giovanni Scambia, David Cibula, Ròbert Póka, Ana Oaknin, Tamar Safra, Beata Maćkowiak-Matejczyk, Ling Ma
Izdano 2021Artigo -
3
519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis od Ana Oaknin, B.J. Monk, L. Polastro, Andréia Cristina de Melo, H.S. Kim, Y.M. Kim, A.S. Lisyanskaya, V. Samouëlian, Domenica Lorusso, Francine Bester Damian, C-L. Chang, S. Takahashi, D. Ramone, Beata Maćkowiak-Matejczyk, J. Li, S. Jamil, M.D. Mathias, M.G. Fury, K.S. Tewari
Izdano 2022Artigo -
4
518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mut... od A.M. Oza, A.S. Lisyanskaya, A.A. Fedenko, A.C. de Melo, Y. Shparik, Igor Bondarenko, N. Colombo, D. Lorusso, D. Cibula, R.L. Póka, A. Oaknin, T. Safra, Beata Maćkowiak-Matejczyk, L. Ma, D. Thomas, K.K. Lin, K. McLachlan, S. Goble, R. Kristeleit
Izdano 2022Artigo -
5
Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomize... od Susana Banerjee, Amit M. Oza, Michael J. Birrer, Erika Hamilton, Jurjees Hasan, Alexandra Léary, Kathleen N. Moore, Beata Maćkowiak-Matejczyk, Joanna Pikiel, Isabelle Ray‐Coquard, Peter C. Trask, Kedan Lin, Eva Schuth, Anjali Vaze, Yoon Jeong Choi, Jim Marsters, Daniel Maslyar, Vanessa Lemahieu, Y. Wang, Eric W. Humke, J F Liu
Izdano 2018Artigo -
6
Survival with Cemiplimab in Recurrent Cervical Cancer od Krishnansu S. Tewari, Bradley J. Monk, Ignace Vergote, Austin Miller, Andréia Cristina de Melo, Hee‐Seung Kim, Yong Man Kim, Alla Lisyanskaya, Vanessa Samouëlian, Domenica Lorusso, Fernanda Damian, Chih‐Long Chang, Evgeniy A. Gotovkin, Shunji Takahashi, Daniella Ramone, Joanna Pikiel, Beata Maćkowiak-Matejczyk, Eva Maria Guerra Alía, Nicoletta Colombo, Yulia Makarova, Danny Rischin, Stéphanie Lheureux, Kosei Hasegawa, Keiichi Fujiwara, Jingjin Li, Shaheda Jamil, Vladimir Janković, Chieh-I Chen, Frank Seebach, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Melissa Mathias, Matthew G. Fury, Ana Oaknin
Izdano 2022Artigo
Alati za pretragu:
Povezani predmeti
Cancer
Internal medicine
Medicine
Oncology
Environmental health
Ovarian cancer
Population
BRCA mutation
Cervical cancer
Chemotherapy
Clinical endpoint
Gastroenterology
Gynecology
Ovarian carcinoma
Randomized controlled trial
Adenocarcinoma
Adverse effect
Biochemistry
Biology
Cancer antigen
Carboplatin
Cisplatin
Confidence interval
Differential diagnosis
Epithelial ovarian cancer
Gemcitabine
Gene
Hazard ratio
Lung cancer
Olaparib